Benitec Biopharma (BNTC) Cash from Operations (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Cash from Operations for 7 consecutive years, with 8213000.0 as the latest value for Q2 2025.

  • Quarterly Cash from Operations fell 148.65% to 8213000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 23588000.0 through Jun 2025, down 21.57% year-over-year, with the annual reading at 23588000.0 for FY2025, 21.57% down from the prior year.
  • Cash from Operations hit 8213000.0 in Q2 2025 for Benitec Biopharma, down from 3086000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1989000.0 in Q1 2021 to a low of 8213000.0 in Q2 2025.
  • Historically, Cash from Operations has averaged 4667611.11 across 5 years, with a median of 4443000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: tumbled 158.65% in 2021 and later soared 50.23% in 2025.
  • Year by year, Cash from Operations stood at 3322000.0 in 2021, then tumbled by 76.25% to 5855000.0 in 2022, then increased by 9.48% to 5300000.0 in 2023, then plummeted by 45.34% to 7703000.0 in 2024, then fell by 6.62% to 8213000.0 in 2025.
  • Business Quant data shows Cash from Operations for BNTC at 8213000.0 in Q2 2025, 3086000.0 in Q1 2025, and 7703000.0 in Q4 2024.